Status:
COMPLETED
Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Factors forecast Chronic Inflammatory Bowel Diseases (IBD) remain at present essentially on clinical factors (extension of the disease, achievement of the perianal ring, requirement of surgery, treatm...
Eligibility Criteria
Inclusion
- Major Patient
- IBD (RCH or MC) diagnosed according to the clinical, endoscopic and histological criteria
- Accepting the sampling of blood
- Patient member or legal successor of a national insurance scheme
- Taken care medical in the service of gastroenterology of CHU de Saint Etienne
- Patient having signed the form of consent
Exclusion
- Minor Patient or uncapable
- Patient suffering from indefinite colitis
- Refusal of the sampling of blood
- Pregnant Woman
- Incapacity or refusal to sign the consent writes
- Subjects deprived of freedom by a court or administrative order
- Use of an anti-TNF. According to the indications ensuing from the Sonic trial or from the strategy " Top Down ".
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT01216514
Start Date
October 1 2010
End Date
July 1 2011
Last Update
November 3 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Gastro-entérologie
Saint-Etienne, France, 42055